EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | chr17:36548360-36548872:+ | ENST00000617860.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSq,AluSx | chr17:36548360-36548872:+.alignment |
chr17:36548360-36548872:+ | ENST00000618837.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSq,AluSx | chr17:36548360-36548872:+.alignment |
chr17:36557901-36559287:+ | ENST00000617860.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | L2a,AluSq2,AluSg,AluSx1 | chr17:36557901-36559287:+.alignment |
chr17:36557901-36559287:+ | ENST00000618837.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | L2a,AluSq2,AluSg,AluSx1 | chr17:36557901-36559287:+.alignment |
chr17:36561675-36563264:+ | ENST00000617860.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSz6,(T)n,AluSg,AluSq2,AluSc8 | chr17:36561675-36563264:+.alignment |
chr17:36561675-36563264:+ | ENST00000618837.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSz6,(T)n,AluSg,AluSq2,AluSc8 | chr17:36561675-36563264:+.alignment |
chr17:36575795-36576446:+ | ENST00000617860.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSx1,AluSq | chr17:36575795-36576446:+.alignment |
chr17:36575795-36576446:+ | ENST00000618837.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSx1,AluSq | chr17:36575795-36576446:+.alignment |
chr17:36584684-36584892:+ | ENST00000618837.3 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluJr | chr17:36584684-36584892:+.alignment |
chr17:36584684-36584892:+ | ENST00000619573.1 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluJr | chr17:36584684-36584892:+.alignment |
chr17:36587585-36588723:+ | ENST00000620927.1 | ENSG00000278311.3 | GGNBP2 | ncRNA_intronic | AluSp,AluSx,AluSc | chr17:36587585-36588723:+.alignment |
ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
chr17:36587585-36588723:+ | BLCA | EER | T_cells_regulatory_(Tregs) | 2.4955e-02 | -0.3049 | .chr17_36587585-36588723_+.png) |
chr17:36587585-36588723:+ | BRCA | EER | Mast_cells_resting | 1.3085e-02 | 0.1894 |  |
ENSG00000278311.3,GGNBP2 | CESC | EAG | T_cells_gamma_delta | 2.2030e-02 | 0.4388 |  |
ENSG00000278311.3,GGNBP2 | COAD | EAG | Dendritic_cells_activated | 2.2444e-02 | 0.3602 |  |
chr17:36561675-36563264:+ | ESCA | EER | Dendritic_cells_activated | 9.9584e-04 | -0.5008 |  |
ENSG00000278311.3,GGNBP2 | ESCA | EAG | T_cells_regulatory_(Tregs) | 4.1822e-02 | -0.2082 | .ENSG00000278311.3,GGNBP2.png) |
chr17:36587585-36588723:+ | GBM | EER | Dendritic_cells_activated | 2.2702e-03 | 0.5279 |  |
ENSG00000278311.3,GGNBP2 | GBM | EAG | Dendritic_cells_activated | 2.4254e-03 | 0.5250 |  |
chr17:36587585-36588723:+ | KIRC | EER | T_cells_CD4_memory_resting | 8.4666e-03 | 0.3124 |  |
ENSG00000278311.3,GGNBP2 | KIRC | EAG | T_cells_CD4_memory_activated | 7.5237e-04 | 0.3832 |  |
chr17:36587585-36588723:+ | KIRP | EER | Macrophages_M2 | 1.7259e-02 | -0.3746 |  |
ENSG00000278311.3,GGNBP2 | KIRP | EAG | Mast_cells_resting | 3.6357e-02 | 0.3129 |  |
ENSG00000278311.3,GGNBP2 | LGG | EAG | Macrophages_M0 | 2.9360e-02 | -0.3405 |  |
chr17:36587585-36588723:+ | LUSC | EER | NK_cells_resting | 4.1432e-02 | -0.2204 |  |
ENSG00000278311.3,GGNBP2 | LUSC | EAG | NK_cells_activated | 4.1984e-02 | 0.2149 |  |
ENSG00000278311.3,GGNBP2 | OV | EAG | Macrophages_M2 | 4.0851e-03 | 0.4733 |  |
ENSG00000278311.3,GGNBP2 | PAAD | EAG | Mast_cells_resting | 2.1644e-02 | 0.5099 |  |
ENSG00000278311.3,GGNBP2 | SARC | EAG | Macrophages_M1 | 4.8123e-03 | 0.5557 |  |
ENSG00000278311.3,GGNBP2 | SKCM | EAG | Mast_cells_resting | 1.5817e-03 | 0.5600 |  |
chr17:36557901-36559287:+ | STAD | EER | Macrophages_M1 | 1.2763e-02 | 0.2826 |  |
chr17:36561675-36563264:+ | STAD | EER | Monocytes | 9.5188e-03 | -0.2520 |  |
chr17:36575795-36576446:+ | STAD | EER | T_cells_gamma_delta | 4.9071e-02 | 0.3507 |  |
ENSG00000278311.3,GGNBP2 | STAD | EAG | Monocytes | 1.4227e-02 | -0.1941 |  |
ENSG00000278311.3,GGNBP2 | THCA | EAG | B_cells_naive | 6.9872e-03 | 0.3697 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
ENSG00000278311.3,GGNBP2 | BLCA | GSVA_HALLMARK_MYOGENESIS | EAG | 1.1282e-02 | 0.3277 |  |
chr17:36587585-36588723:+ | BLCA | GSVA_HALLMARK_HYPOXIA | EER | 2.7047e-02 | 0.3009 |  |
ENSG00000278311.3,GGNBP2 | BRCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EAG | 7.6099e-03 | -0.1972 |  |
chr17:36587585-36588723:+ | BRCA | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 1.0142e-02 | 0.1961 |  |
ENSG00000278311.3,GGNBP2 | CESC | GSVA_HALLMARK_ALLOGRAFT_REJECTION | EAG | 9.5888e-04 | 0.5992 |  |
ENSG00000278311.3,GGNBP2 | COAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 1.7142e-02 | -0.3749 |  |
chr17:36561675-36563264:+ | ESCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 1.2871e-02 | 0.3899 |  |
ENSG00000278311.3,GGNBP2 | ESCA | GSVA_HALLMARK_ANGIOGENESIS | EAG | 3.0566e-02 | 0.2209 |  |
chr17:36587585-36588723:+ | GBM | GSVA_HALLMARK_P53_PATHWAY | EER | 7.3163e-03 | 0.4722 |  |
ENSG00000278311.3,GGNBP2 | GBM | GSVA_HALLMARK_P53_PATHWAY | EAG | 6.7739e-03 | 0.4762 |  |
ENSG00000278311.3,GGNBP2 | LAML | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 2.0864e-02 | 0.2221 |  |
ENSG00000278311.3,GGNBP2 | LGG | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 1.4931e-02 | 0.3776 |  |
ENSG00000278311.3,GGNBP2 | LUAD | GSVA_HALLMARK_APOPTOSIS | EAG | 2.8825e-02 | 0.1797 |  |
chr17:36587585-36588723:+ | LUAD | GSVA_HALLMARK_BILE_ACID_METABOLISM | EER | 4.9789e-03 | -0.2422 |  |
ENSG00000278311.3,GGNBP2 | LUSC | GSVA_HALLMARK_DNA_REPAIR | EAG | 2.8432e-02 | 0.2311 |  |
chr17:36587585-36588723:+ | LUSC | GSVA_HALLMARK_DNA_REPAIR | EER | 3.7213e-02 | 0.2251 |  |
ENSG00000278311.3,GGNBP2 | SARC | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 3.1378e-02 | -0.4401 |  |
ENSG00000278311.3,GGNBP2 | SKCM | GSVA_HALLMARK_ANDROGEN_RESPONSE | EAG | 8.7477e-03 | -0.4779 |  |
chr17:36557901-36559287:+ | STAD | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 7.5279e-03 | 0.3024 |  |
chr17:36575795-36576446:+ | STAD | GSVA_HALLMARK_KRAS_SIGNALING_UP | EER | 1.2759e-02 | 0.4354 |  |
ENSG00000278311.3,GGNBP2 | STAD | GSVA_HALLMARK_MTORC1_SIGNALING | EAG | 4.4462e-02 | 0.1596 |  |
ENSG00000278311.3,GGNBP2 | TGCT | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 2.4862e-03 | 0.5885 |  |
ENSG00000278311.3,GGNBP2 | THCA | GSVA_HALLMARK_ANDROGEN_RESPONSE | EAG | 1.2955e-03 | 0.4343 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
ENSG00000278311.3,GGNBP2 | BLCA | Imatinib | EAG | 4.4955e-02 | -0.2621 |  |
chr17:36587585-36588723:+ | BLCA | Cisplatin | EER | 4.7587e-02 | -0.2709 |  |
ENSG00000278311.3,GGNBP2 | BRCA | Bryostatin.1 | EAG | 1.5156e-02 | -0.1798 |  |
chr17:36587585-36588723:+ | BRCA | A.770041 | EER | 3.5356e-03 | -0.2219 |  |
ENSG00000278311.3,GGNBP2 | CESC | AZD6244 | EAG | 7.3663e-03 | -0.5039 |  |
ENSG00000278311.3,GGNBP2 | COAD | LFM.A13 | EAG | 3.8718e-03 | -0.4466 |  |
chr17:36561675-36563264:+ | ESCA | CCT018159 | EER | 1.5656e-02 | 0.3797 |  |
ENSG00000278311.3,GGNBP2 | ESCA | Elesclomol | EAG | 2.7759e-02 | -0.2247 |  |
chr17:36587585-36588723:+ | GBM | ABT.888 | EER | 1.9921e-02 | 0.4160 |  |
ENSG00000278311.3,GGNBP2 | GBM | ABT.888 | EAG | 2.1501e-02 | 0.4114 |  |
ENSG00000278311.3,GGNBP2 | KIRC | JNK.9L | EAG | 4.3301e-06 | 0.5056 |  |
chr17:36587585-36588723:+ | KIRC | JNK.9L | EER | 7.0454e-06 | 0.5083 |  |
chr17:36587585-36588723:+ | KIRP | BI.D1870 | EER | 1.5028e-02 | 0.3819 |  |
ENSG00000278311.3,GGNBP2 | KIRP | BI.D1870 | EAG | 1.3884e-02 | 0.3643 |  |
ENSG00000278311.3,GGNBP2 | LAML | JNK.Inhibitor.VIII | EAG | 3.0230e-02 | -0.2086 |  |
ENSG00000278311.3,GGNBP2 | LGG | CGP.60474 | EAG | 1.9138e-03 | 0.4704 |  |
ENSG00000278311.3,GGNBP2 | LUAD | BIBW2992 | EAG | 5.1093e-04 | -0.2822 |  |
chr17:36587585-36588723:+ | LUAD | AG.014699 | EER | 5.9941e-04 | -0.2938 |  |
ENSG00000278311.3,GGNBP2 | LUSC | CI.1040 | EAG | 1.4253e-02 | 0.2576 |  |
chr17:36587585-36588723:+ | LUSC | AP.24534 | EER | 1.4282e-02 | 0.2634 |  |
ENSG00000278311.3,GGNBP2 | OV | AICAR | EAG | 7.4811e-03 | 0.4444 |  |
ENSG00000278311.3,GGNBP2 | PAAD | Doxorubicin | EAG | 3.1473e-02 | 0.4818 |  |
ENSG00000278311.3,GGNBP2 | SARC | BI.2536 | EAG | 8.6840e-03 | -0.5233 |  |
ENSG00000278311.3,GGNBP2 | SKCM | Erlotinib | EAG | 2.1465e-03 | -0.5468 |  |
chr17:36557901-36559287:+ | STAD | ABT.263 | EER | 3.1415e-02 | 0.2455 |  |
chr17:36575795-36576446:+ | STAD | BMS.708163 | EER | 4.8196e-02 | -0.3520 |  |
chr17:36561675-36563264:+ | STAD | AZD.2281 | EER | 4.8863e-02 | -0.1937 |  |
ENSG00000278311.3,GGNBP2 | TGCT | CI.1040 | EAG | 4.0501e-02 | -0.4210 |  |
ENSG00000278311.3,GGNBP2 | THCA | BMS.708163 | EAG | 1.8914e-03 | -0.4209 |  |